Dexterra Group (13N1) AI Stock Analysis

1 Followers

Dexterra Group

(Frankfurt:13N1)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Broad-based growth and margin expansionGrowth across facilities management and workforce accommodation, combined with higher EBITDA margins, indicates improving operating execution rather than reliance on a single contract or activity. Continued organic expansion and acquisition contribution can strengthen earnings power over the next several quarters.

Negative Factors

Higher balance-sheet leverageThe substantial increase in debt relative to equity reduces financial flexibility compared with Dexterra’s 2023–2024 position. Although current leverage has improved from the 2025 year-end level, a larger debt burden can constrain acquisitions, investment, and resilience if operating conditions weaken.

Dexterra Group (13N1) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.23B
Dividend Yield: 1.96%
Average Volume (3M): ―
Price to Earnings (P/E): 27.6
Beta (1Y): 0.25
Revenue Growth: 4.29%
EPS Growth: 9.83%
Country: Germany
Employees: 8,594
Sector: Industrials
Sector Strength: 63
Industry: Specialty Business Services

Dexterra Group Business Overview & Revenue Model

Company Description

Dexterra Group Inc., established in 1985 and based in Mississauga, Canada, offers extensive support services essential for the development, upkeep, and operation of infrastructure projects throughout Canada. The company organizes its operations into...

Dexterra Group Earnings Call Summary

Earnings Call Date:Nov 03, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Mar 09, 2027

Earnings Call SentimentPositive

The call was strongly positive overall. Dexterra reported record annual adjusted EBITDA, revenue and EBITDA growth, margin expansion, strong free cash flow, improved leverage, achievement of its return on equity target, and progress across its Canadian and U.S. growth initiatives. The main negative factors were unusually low wildfire support activity, a CAD 10 million year-over-year decline in installation and demobilization revenue due to project timing, near-term PVC cash flow neutrality, and uncertainty around the timing of project awards and data center expansion.

Positive Updates

Record EBITDA and Strong Q3 Financial Performance

Management described Q3 as traditionally Dexterra's strongest quarter and reported record annual adjusted EBITDA, revenue of CAD 291 million versus CAD 281 million last year, adjusted EBITDA of CAD 38 million, up 9% year-over-year, adjusted EBITDA margin of 13% versus 12.5%, and adjusted net earnings per share of CAD 0.28, up 12%.

Negative Updates

Significantly Lower Wildfire Support Activity

Wildfire support activity was lower than normal and was described as approximately half of, or even a little less than, a typical year. Management said it was a very low year, with some activity but not much, compared with a nominal target of approximately CAD 25 million.

Company Guidance

Management expects support services adjusted EBITDA margins to exceed 9% over the medium term and be in that 9% range, while Asset Based Services adjusted EBITDA margins are expected to be overall at the higher end of our 30%-40% range in 2026. The company continues to expect to generate the majority of its free cash flow in the back half of 2026, with annual adjusted EBITDA to free cash flow conversion to exceed 50%, and remains committed to net debt to adjusted EBITDA of less than 2.5x. New FM and IFM contracts are expected to mobilize and ramp up through the first half of 2027; installation and demobilization activity is expected to include some in Q4, more in 2027, and be probably increasing through 2027. Dexterra expects to acquire additional beds over the next 12 months, including an additional 1,500 beds, with approximately 2,500 beds available for deployment over the medium term, increasing deployable capacity by 4,000 total and overall fleet capacity to 14,000 beds total.

Dexterra Group Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

DE:13N1 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:KBL	74Outperform	CAD 541.69M	24.58	7.89%	2.91%	46.60%	-4.27%
TSE:CGY	69Neutral	CAD 1.01B	24.70	11.67%	1.34%	15.72%	―
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

* Industrials Sector Average

Performance Comparison

DE:13N1 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:13N1	Dexterra Group Inc.	11.90	6.09	104.75%
TSE:CGY	Calian Group Ltd.	83.47	35.27	73.17%
TSE:KBL	K-Bro Linen	41.30	6.09	17.31%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Dexterra Group AI Stock Analysis